{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T19:02:10Z","timestamp":1760122930655},"reference-count":25,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"name":"none","award":["N\/A"],"award-info":[{"award-number":["N\/A"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"abstract":"<jats:sec><jats:title>Abstract<\/jats:title><jats:p>The diagnosis of acute coronary syndrome (ACS) in patients with cancer constitutes a therapeutic challenge. We aimed to assess the clinical presentation and management of ACS as well as 1-year survival in patients hospitalized for cancer.<\/jats:p><jats:p>This retrospective study included patients hospitalized between 2012 and 2018 in a nonacademic center. The inclusion criteria were diagnosis of active cancer and ACS recognized using standard criteria. Patients were assessed with respect to invasive or conservative ACS strategy. The primary endpoint was all-cause mortality, and the secondary endpoint was cardiovascular mortality during 1-year follow-up.<\/jats:p><jats:p>We screened 25,165 patients, of whom 36 (0.14%) had ACS (mean [SD] age, 71.9 [9.8] years). The most common presentation was non\u2013ST-segment elevation myocardial infarction (61% of patients). Coronary angiography was performed in 47% of patients, while 53% were treated conservatively. Overall, the primary endpoint occurred in 67% of patients and secondary endpoint in 28% during follow-up. The predictors of better outcome in a univariate analysis were invasive strategy, lack of metastases, aspirin use, and no cardiogenic shock. Invasive treatment and aspirin use remained significant predictors of better survival when adjusted for the presence of metastases (hazard ratio [HR] 0.37, confidence interval [CI] 0.15\u20130.92 and HR 0.39, CI 0.16\u20130.94, respectively) and ineligibility for cancer treatment (HR 0.37, CI 0.15\u20130.93 and HR 0.30, CI 0.12\u20130.73, respectively).<\/jats:p><jats:p>The incidence of ACS in cancer patients is low but 1-year mortality rates are high. Guideline-recommended management was frequently underused. Our results suggest that invasive approach and aspirin use are associated with better survival regardless of cancer stage and eligibility for cancer treatment.<\/jats:p><\/jats:sec>","DOI":"10.1097\/md.0000000000018972","type":"journal-article","created":{"date-parts":[[2020,1,30]],"date-time":"2020-01-30T02:31:13Z","timestamp":1580351473000},"page":"e18972","source":"Crossref","is-referenced-by-count":11,"title":["Clinical presentation and treatment of acute coronary syndrome as well as 1-year survival of patients hospitalized due to cancer"],"prefix":"10.1097","volume":"99","author":[{"given":"Katarzyna","family":"Styczkiewicz","sequence":"first","affiliation":[{"name":"Department of Cardiology, Specialist Hospital in Brzoz\u00f3w, Subcarpathian Oncological Center, Brzoz\u00f3w"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marek","family":"Styczkiewicz","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Specialist Hospital in Brzoz\u00f3w, Subcarpathian Oncological Center, Brzoz\u00f3w"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Monika","family":"My\u0107ka","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Specialist Hospital in Brzoz\u00f3w, Subcarpathian Oncological Center, Brzoz\u00f3w"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sabina","family":"M\u0119drek","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Specialist Hospital in Brzoz\u00f3w, Subcarpathian Oncological Center, Brzoz\u00f3w"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomasz","family":"Kondraciuk","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Specialist Hospital in Brzoz\u00f3w, Subcarpathian Oncological Center, Brzoz\u00f3w"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Czerkies-Biele\u0144","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Specialist Hospital in Brzoz\u00f3w, Subcarpathian Oncological Center, Brzoz\u00f3w"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrzej","family":"Wi\u015bniewski","sequence":"additional","affiliation":[{"name":"Subcarpathian Center for Cardiovascular Intervention, G.V.M. Carint, Sanok"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sebastian","family":"Szmit","sequence":"additional","affiliation":[{"name":"Department of Pulmonary Circulation, Thromboembolic Diseases and Cardiology, Centre of Postgraduate Medical Education, Otwock"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Piotr","family":"Jankowski","sequence":"additional","affiliation":[{"name":"1st Department of Cardiology, Interventional Electrocardiology and Hypertension, Institute of Cardiology, Jagiellonian University Medical College, Krak\u00f3w, Poland."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2020,1]]},"reference":[{"key":"R1-20230915","doi-asserted-by":"crossref","first-page":"244","DOI":"10.20452\/pamw.4254","article-title":"Optimal management of cancer patients with acute coronary syndrome","volume":"128","author":"Banasiak","year":"2018","journal-title":"Pol Arch Intern Med"},{"key":"R2-20230915","first-page":"439","article-title":"The impact of cardiac and noncardiac comorbidities on the short-term outcomes of patients hospitalized with acute myocardial infarction: a population-based perspective","volume":"5","author":"Chen","year":"2013","journal-title":"Clin Epidemiol"},{"key":"R3-20230915","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1016\/j.jacc.2017.06.047","article-title":"Risk of arterial thromboembolism in patients with cancer","volume":"70","author":"Navi","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"R4-20230915","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1182\/blood-2018-06-860874","article-title":"Arterial thromboembolic events preceding the diagnosis of cancer in older persons","volume":"133","author":"Navi","year":"2019","journal-title":"Blood"},{"key":"R5-20230915","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.5603\/KP.2018.0203","article-title":"Fourth universal definition of myocardial infarction (2018) [in Polish]","volume":"76","author":"Thygesen","year":"2018","journal-title":"Kardiol Pol"},{"key":"R6-20230915","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.5603\/KP.2016.0156","article-title":"2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines [in Polish]","volume":"74","author":"Zamorano","year":"2016","journal-title":"Kardiol Pol"},{"issue":"(Suppl 1)","key":"R7-20230915","doi-asserted-by":"crossref","first-page":"S23","DOI":"10.1016\/j.thromres.2018.01.003","article-title":"Arterial thrombosis and cancer","volume":"164","author":"Aronson","year":"2018","journal-title":"Thromb Res"},{"key":"R8-20230915","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.5603\/KP.2018.0228","article-title":"2018 ESC\/EACTS Guidelines on myocardial revascularization [in Polish]","volume":"76","author":"Neumann","year":"2018","journal-title":"Kardiol Pol"},{"key":"R9-20230915","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.5603\/KP.2015.0243","article-title":"2015 ESC guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation [in Polish]","volume":"73","author":"Roffi","year":"2015","journal-title":"Kardiol Pol"},{"key":"R10-20230915","doi-asserted-by":"crossref","first-page":"229","DOI":"10.5603\/KP.2018.0041","article-title":"2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation [in Polish]","volume":"76","author":"Ibanez","year":"2018","journal-title":"Kardiol Pol"},{"key":"R11-20230915","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1177\/2048872617706501","article-title":"Prevalence and outcome of patients with cancer and acute coronary syndrome undergoing percutaneous coronary intervention: a BleeMACS substudy","volume":"7","author":"Iannaccone","year":"2018","journal-title":"Eur Heart J Acute Cardiovasc Care"},{"key":"R12-20230915","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1007\/s00432-015-2056-5","article-title":"Analysis of outcomes of percutaneous coronary intervention in metastatic cancer patients with acute coronary syndrome over a 10-year period","volume":"142","author":"Guddati","year":"2016","journal-title":"J Cancer Res Clin Oncol"},{"key":"R13-20230915","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/s40256-016-0196-x","article-title":"Optimal medical therapy in patients with malignancy undergoing percutaneous coronary intervention for acute coronary syndrome: a BleeMACS Sub-Study","volume":"17","author":"D Iannaccone","year":"2017","journal-title":"Am J Cardiovasc Drugs"},{"key":"R14-20230915","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1002\/clc.22007","article-title":"Treatment and outcomes of acute coronary syndrome in the cancer population","volume":"35","author":"Yusuf","year":"2012","journal-title":"Clin Cardiol"},{"key":"R15-20230915","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.ijcard.2018.10.008","article-title":"Acute coronary syndromes in patients with active hematologic malignancies: incidence, management, and outcomes","volume":"275","author":"Park","year":"2019","journal-title":"Int J Cardiol"},{"key":"R16-20230915","first-page":"115","article-title":"Management and mortality in patients with non-ST-segment elevation vs. ST-segment elevation myocardial infarction. Data from the malopolska registry of acute coronary syndromes","volume":"67","author":"Dziewierz","year":"2009","journal-title":"Kardiol Pol"},{"key":"R17-20230915","doi-asserted-by":"crossref","first-page":"5","DOI":"10.24292\/01.OR.260318","article-title":"Acute coronary syndromes in oncology: conservative or invasive strategies? Case study and literature review","volume":"1","author":"Wilk","year":"2018","journal-title":"OncoReview"},{"key":"R18-20230915","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1002\/cncr.22434","article-title":"Impact of aspirin therapy in cancer patients with thrombocytopenia and acute coronary syndromes","volume":"109","author":"Sarkiss","year":"2007","journal-title":"Cancer"},{"key":"R19-20230915","doi-asserted-by":"crossref","first-page":"508","DOI":"10.5603\/KP.2017.0087","article-title":"Polish forum for prevention guidelines on prophylactic pharmacotherapy: update 2017","volume":"75","author":"Podolec","year":"2017","journal-title":"Kardiol Pol"},{"key":"R20-20230915","doi-asserted-by":"crossref","first-page":"187","DOI":"10.5603\/KP.2017.0031","article-title":"Polish forum for prevention guidelines on dyslipidaemia: update 2016","volume":"75","author":"Cybulska","year":"2017","journal-title":"Kardiol Pol"},{"key":"R21-20230915","first-page":"295","article-title":"Tele-cardio-onco AID: a new concept for a coordinated care program in breast cancer (BREAST-AID): rationale and study protocol","volume":"129","author":"Styczkiewicz","year":"2019","journal-title":"Pol Arch Intern Med"},{"key":"R22-20230915","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1177\/2048872617729636","article-title":"Treatment of patients with myocardial infarction depends on history of cancer","volume":"7","author":"Rohrmann","year":"2018","journal-title":"Eur Heart J Acute Cardiovasc Care"},{"key":"R23-20230915","first-page":"221","article-title":"Risk factors for myocardial infarction in cancer patients","volume":"26","author":"Ogawa","year":"1995","journal-title":"J Med"},{"key":"R24-20230915","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.amjmed.2010.07.023","article-title":"Recent trends in the incidence, treatment, and outcomes of patients with STEMI and NSTEMI","volume":"124","author":"McManus","year":"2011","journal-title":"Am J Med"},{"key":"R25-20230915","first-page":"591","article-title":"Risk factors for gastric cancer: a systematic review","volume":"19","author":"Yusefi","year":"2018","journal-title":"Asian Pac J Cancer Prev"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000018972","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,30]],"date-time":"2024-07-30T21:16:12Z","timestamp":1722374172000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000018972"}},"subtitle":["A 7-year experience of a nonacademic center"],"short-title":[],"issued":{"date-parts":[[2020,1]]},"references-count":25,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000018972","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"type":"print","value":"0025-7974"},{"type":"electronic","value":"1536-5964"}],"subject":[],"published":{"date-parts":[[2020,1]]}}}